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. This endolysosomal sorting is mediated by the budding of portions of the endosome's limiting membrane into the lumen of the endosome. These membrane buds are cleaved through a membrane scission reaction to form intralumenal vesicles (ILVs) in the endosome. Late endosomes filled with ILVs are referred to as multivesicular bodies (MVBs) or sometimes multivesicular endosomes [2] [3] [4] . Once formed, MVBs fuse with one another and the lysosome in a process directed by the HOPS and CORVET complexes 5 , and their contents are degraded. Because budding in the endolysosomal pathway is directed away from the cytosol, it differs fundamentally from the well-studied conventional vesicle budding reactions that are directed into the cytosol. Many such reactions are mediated by a complex but conceptually straightforward mechanism in which coat proteins impose curvature on the cytosolic face of the bud. The best-known of these are clathrin and the coat protein (COP) complexes, which cooperate with scission factors to cleave membrane tubes from the outside and thereby release vesicles into the cytosol. Dynamin, the most studied scission factor, achieves membrane scission in an intuitively clear (but still debated) reaction 6 .
The formation of ILVs requires a fundamentally different machinery, in which cytosolic factors promote the formation and cleavage of buds (and the necks connecting them to the limiting membrane) from the inside of the membrane neck.
Studies in Saccharomyces cerevisiae have been integral for identifying the factors involved in forming MVBs in the endosomal pathway. In yeast, the equivalent of the mammalian lysosome is the vacuole, the biogenesis of which is linked to that of MVBs and is regulated by vacuolar protein sorting (VPS) genes. A subset of VPS genes, known as class E genes, encode proteins that are directly involved in MVB biogenesis 7 . Indeed, deleting any of these genes leads to the formation of an abnormal multicisternal endosome lacking internal vesicles, referred to as a class E compartment. Many of these proteins are core subunits of four complexes that have been dubbed the endosomal sorting complexes required for transport (ESCRTs): ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III [8] [9] [10] (TABLE 1) . The rest of the class E VPS proteins include the AAA+ ATPase Vps4, which provides the only direct energy input to the pathway by hydrolysing ATP, regulatory proteins that modulate ESCRT disassembly and the multifunctional ESCRT-associated protein Bro1 domain-containing protein 1 (Bro1; known in metazoa as ALIX and PDCD6IP).
In addition to MVB biogenesis, the ESCRTs are required for cytokinesis [11] [12] [13] , budding of HIV-1 and other enveloped viruses 14, 15 , and macroautophagy (autophagy for short) 16, 17 (FIG. 1) . All of these pathways involve the cleavage of membrane necks with the same unconventional topology as in MVB biogenesis (discussed below). Until 2 years ago, the mechanisms of membrane remodelling by the ESCRTs were almost purely a matter of conjecture.
Step by step analysis of ESCRT function using classical approaches in vivo was hampered by the fact that deletion of any of the required pathway components induces the formation of aberrant class E compartments, which are devoid of internal vesicles [18] [19] [20] . Furthermore, the structure of the class E compartment is the same, regardless of whether it is induced by deletion of genes with primary roles in cargo sorting, membrane budding, membrane scission or ESCRT recycling. However, recent in vitro studies have provided new insight into the function of each of the major ESCRT complexes and moved forward our thinking about the underlying mechanisms of membrane remodelling. Particularly important advances have come from electron microscopy (EM) analysis of membrane tubules formed by over expressed or purified ESCRT-III subunits [21] [22] [23] [24] , reconstitution of budding and scission in giant unilamellar vesicles (GUVs) [25] [26] [27] and computational analyses 28, 29 .
In this Review, we describe the mechanisms of membrane deformation, budding and scission that are associated with the ESCRTs. The reader is directed elsewhere for excellent reviews of the cell biology [30] [31] [32] , biochemistry and structural biology 33-36 of these proteins. We organize our discussion around the steps required to deform and then remodel the membrane to create lumenal vesicles in MVBs. Although vesicle formation in MVB biogenesis is at least in part initiated by ubiquitin moieties attached to cargo molecules, ubiquitin is not strictly required for the mechanics of budding into MVBs and has not been shown to be crucial for neck cleavage in any of the ESCRT-dependent pathways. The central role of ubiquitin in directing cargo into the ESCRT pathway has recently been reviewed elsewhere 37 and so will not be considered in detail here.
Organization of the ESCRTs ESCRT-I and ESCRT-II are directly involved in membrane budding, whereas ESCRT-III is responsible for membrane scission. The structural organization of these three complexes, which of all the ESCRTs and ESCRTassociated proteins are the most relevant to this Review, is described in detail below.
ESCRT-I.
ESCRT-I is a constitutively assembled hetero tetramer consisting of one copy each of the subunits Vps23 (also known as Stp22), Vps28, Vps37 (also known as Srn2) and multivesicular body sorting factor 12 (Mvb12) [38] [39] [40] [41] (FIG. 2a,b) . The complex is centred around a 13-nm-long stalk and a 5-nm-long headpiece 41 . Projecting from the stalk that corresponds to the amino termini of Vps23 and Vps37 is the region that contains the ubiquitin E2 variant (UEV) domain of Vps23, which binds to ESCRT-0 (REFS 42-44), the PTAP motifs of the HIV-1 Gag protein and certain other viral proteins 45 , and ubiquitylated cargo 10, 46, 47 . A short carboxy-terminal ubiquitin-binding domain in Mvb12 is also found at this end of the stalk 48 . Also at this end, the basic N-terminal helix of Vps37 is involved in electrostatic interactions with acidic membrane lipids 41 , and the linker between the UEV domain and the stalk contains a GPPXXY motif that targets ESCRT-I to midbodies during cytokinesis 12, 13, 49 . At the opposite end, a C-terminal helical domain of Vps28 projects out to bind to the ESCRT-II complex [50] [51] [52] .
ESCRT-II.
ESCRT-II is also a constitutively assembled heterotetramer, comprising one molecule of Vps22 (also known as Snf8) and Vps36 and two molecules of Vps25. The complex has a rigid Y-shaped core, and the overall structure has a maximum dimension of ~15 nm [53] [54] [55] ( FIG. 2a,b ). Vps22 and Vps36 have an intimate and extensive interface, and the two copies of Vps25 associate with the Vps22-Vps36 subcore through smaller interfaces. Both copies of Vps25 are essential for ESCRT-II function 53, 56 . A short PPXY motif at the N terminus of the first winged helix (WH) motif of Vps25 binds to structurally analogous pockets in the C-terminal WH motifs of Vps22 and Vps36. The C-terminal WH motifs of Vps25 bind to, recruit and activate the most Other ESCRT-dependent viruses have varying requirements for specific components of the ESCRT machinery, but all require ESCRT-III and VPS4. e | Cytokinesis in animal cells requires ESCRT-I, ESCRT-III, VPS4 and ALIX, which have been shown to localize to the midbody during cytokinesis in the appropriate time and place to carry out the final cleavage of the membrane neck, separating the two daughter cells. Cytokinesis in Crenarchaeota requires homologues of ESCRT-III and VPS4. f | Autophagy requires all the ESCRTs, similarly to MVB biogenesis, although it is not clear whether their roles in autophagy are direct or indirect. There is an intriguing analogy between the closure of the phagophore neck and the formation of ILVs, making it tempting to speculate that the ESCRTs are involved in closing this neck. However, the presence of ESCRTs at the phagophore neck has never been visualized.
Gag protein
The protein product of the HIV-1 gag gene, consisting of four functional segments: MA, CA, NC and p6. The p6 segment contains the motifs PTAP and YPXL, which bind to ESCRT-I and ALIX, respectively.
Midbody
A dense protein structure located at the centre of the narrow membrane neck that connects two dividing cells.
upstream ESCRT-III subunit, Vps20 (REFS 26, 54, 57) . The N terminus of Vps22 contains a basic helix that interacts nonspecifically with acidic lipids and is important for the membrane recruitment of ESCRT-II 55 . The N terminus of yeast Vps36 is complex. Yeast Vps36 contains a variant pleckstrin homology (PH) domain known as a GRAM-like ubiquitin-binding in EAP45 (GLUE) domain, into the sequence of which two Npl4-type zinc finger (NZF) domains have been inserted 52 . In yeast Vps36, the GLUE domain binds to 3-phosphoinositide s 52 , NZF1 binds to ESCRT-I 51 , and NZF2 binds to ubiquitylated cargo 58 . Human VPS36 has a simpler architecture, in which the GLUE domain has no insertions and binds directly to both 3-phosphoinositides and ubiquitin [59] [60] [61] .
ESCRT-III. Unlike the other ESCRTs, which are stable heteropolymers, ESCRT-III is a dynamic polymer of ESCRT-III proteins that does not have a clearly defined or unique composition. In yeast, ESCRT-III consists of four core subunits -Vps20, Snf7, Vps24 and Vps2 (also known as DOA4-independent degradation protein 4 (Did4)) 9 -and three peripheral or regulatory subunits -Did2, Vps60 and increased sodium tolerance protein 1 (Ist1) (TABLE 1) . This list of ESCRT-III sub units expands to include twelve proteins in humans. The human proteins include three isoforms of SNF7 and two each of DID2 and VPS2. In yeast, all seven proteins seem to work together in MVB biogenesis, and the various isoforms of the human proteins may function similarly and form alternative complexes. Studies of the ESCRT-III complex in yeast suggest a model in which Vps20 initiates polymer assembly, Snf7 extends the polymer and is its major constituent, and Vps24 and Vps2 act to cap the polymer, thereby limiting its size 62 . The three peripheral subunits seem to assemble later than the four core subunits and may play a part in regulating complex disassembly. A representative ESCRT-III polymer created by overexpressing human SNF7 together with an inactive mutant of VPS4B in cultured cells is shown in FIG. 3a . All ESCRT-III proteins share a common overall architecture; representative crystal structures show that they are a 7-nm-long α-helical hairpin buttressed by several short helices 24, 63, 64 ( FIG. 3b) . ESCRT-III proteins also have the common behaviour of cycling between a closed monomeric state in the cytosol and an open polymerized state on the endosomal membrane 65, 66 (see below) (FIG. 3c) . Assembly of the ESCRT-III polymer is energetically favourable and highly regulated. The closed cytosolic conformation of each ESCRT-III protein is maintained by intramolecular autoinhibitory interactions in which sequences in the C-terminal α5 and α6 helices hide residues along the hairpin surface that are responsible for membrane binding and polymer assembly. Once the ESCRT-III proteins bind the membrane, interactions between the subunits require hydrophobic residues near the tip of the helical hairpin 24, 63, 64 . Analysis of variability in crystal contacts in various ESCRT-III structures and a low resolution cryo-EM reconstruction have led to some reasonable inferences about which contacts are important in polymer assembly, but these need to be confirmed by higher resolution EM analysis and additional functional corroboration.
Membrane budding
The first step in creating a lumenal vesicle is to deform the membrane into a bud. In this Review, we use the term bud to describe a nascent vesicle (or virion) that is still attached to the limiting membrane -in other words, before scission -and the term ILV to refer to a detached vesicle subsequent to membrane scission. In vitro analyses using purified proteins and GUVs show that large buds can be formed in vitro by recruiting either ESCRT-I and ESCRT-II together 27 or the Vps20 and Snf7 subunits of ESCRT-III 25, 57 to an appropriate membrane surface. ESCRT-I and ESCRT-II colocalize almost exclusively to the necks of such buds and seem to act by stabilizing the bud neck (FIG. 4a,b) . ESCRT-I and ESCRT-II are extremely potent inducers of bud formation and are effective even at concentrations of 15 nM, below their estimated physiological concentrations of ~75 nM in yeast cells. The ESCRT-III subunits Vps20 and Snf7 can also induce bud formation, but only at superphysiological concentrations (600 nM for Snf7). When ESCRT-I and ESCRT-II induce bud formation in vitro, ESCRT-III subunits are recruited only to the bud necks and are not substantially present in the lumen, consistent with physiology. However, Vps20-and 
Lipid modification
Snf7-induced buds contain ESCRTs in the lumen of the bud, in contrast to the physiological situation, in which ESCRTs are recycled and therefore not concentrated in buds. The mechanism by which ESCRT-III subunits proceed to carry out scission at the necks of ESCRT-I-and ESCRT-II-induced buds is discussed in detail below.
Recent in vitro studies support the idea that ESCRT-I and ESCRT-II play the central part in membrane budding. Physiological concentrations of ESCRT-I and ESCRT-II, but not ESCRT-III, drive bud formation in reconstituted reactions in GUVs. In these in vitro studies, buds formed by ESCRT-I and ESCRT-II on the GUVs, but not those formed by ESCRT-III, exclude ESCRTs from the lumen on the bud, consistent with physiology. Finally, bud necks formed by ESCRT-I and ESCRT-II are able to recruit ESCRT-III, which, in this setting, then cleaves the membrane necks with the appropriate topology (that is, from the surface contiguous with the inside of the membrane neck). Importantly, however, all of these complexes share a propensity to localize at and stabilize membrane necks. Structures of necklike assemblies of ESCRT-III have been visualized by EM 21, 22 (FIG. 3a) . However, the structure of the ESCRT-I and ESCRT-II membrane neck assembly is currently unknown; elucidating these structures will be crucial to further understand the pathway and mechanism by which ESCRTs promote membrane budding.
Bud formation by ESCRT-I and ESCRT-II involves the docking of the interacting motifs of the two complexes 51 , such that in an ESCRT-I-ESCRT-II supercomplex the membrane-binding sites on the two complexes are rigidly separated by at least 18 nm. The dimensions of the physio logical bud neck are not well characterized, as these structures are short-lived during the normal budding process in cells and are rarely detected by EM 67 . Although it seems that buds begin with wide-necked membrane invaginations (FIG. 4c) , there is currently limited experimental information on the pathway of budding. In any case, the bud neck diameter can reasonably be expected to be equal to or smaller than the diameter of the final ILV, which is ~25 nm in yeast and ~50 nm in human cells. This suggests a potential mechanism for stabilizing the formation of a bud neck of these dimensions (FIG. 4b) , as the length of the complexes is similar to the probable initial dimensions of the neck. Clearly, the kinetic mechanism and energy landscape of the budding trajectory will require further analysis, and much remains to be learned about the mechanism underlying bud formation.
Membrane scission
Once a bud is created, its separation from the parent membrane requires scission. The ESCRT-III complex catalyses the scission of membrane necks 25 . The scission reaction that occurrs in yeast MVB biogenesis 62 and is reconstituted in GUVs 25 involves the assembly of Vps20, Snf7 and Vps24, in that order and in a loosely defined ratio, at the membrane neck 27 (FIG. 5a) . Of all the ESCRT-III subunits, only Snf7, the most abundant ESCRT-III protein in yeast, is absolutely required for severing. Vps20 is present at lower concentrations than Snf7 and couples ESCRT-II to ESCRT-III 26, 54, 56, 57 . The coupling of ESCRT-II to Vps20 is required for MVB biogenesis, but it does not seem to be required for ESCRT-II-independent pathways such as HIV-1 budding and cytokinesis 13, 68, 69 (see below). Vps24 also operates at low concentrations, and its omission sharply slows but does not completely block scission 25 . Energy for the scission reaction is provided by the strong intersubunit and subunit-membrane contacts formed as ESCRT-III assembles on the membrane. An energetically plausible model for the structure responsible for scission 29 (FIG. 5b) has been suggested that is inspired by the dome-shaped tip of helical lipid-coated protein tubules formed by VPS2 and VPS24 in vitro 29 and is consistent with the tubules seen emerging from cells overexpressing human SNF7 (FIG. 3a) . Importantly, this model has as a starting point the presence of a membrane deformation or bud, which could be created by the combined action of ESCRT-I and ESCRT-II, as discussed above. In this working model for scission 29 , the basic face of an ESCRT-III dome makes strong, favourable electrostatic contacts with the acidic membrane. The interaction energy per unit area between the membrane and the ESCRT-III dome becomes a crucial parameter in determining whether the energy barrier to scission and accompanying release of the vesicle can be overcome. Provided they are strong enough, the protein-membrane interactions draw the membrane to enfold the top of the dome. As the membrane envelops the top of the dome, the neck narrows to ~3 nm and a scission intermediate is spontaneously formed. Although human VPS2 and VPS24 can form structures in vitro that would seem to have the potential to catalyse scission 22, 29 , it has yet to be shown that they have membrane scission activity in the absence of SNF7. Indeed, in vitro and in vivo studies with yeast proteins suggest that Snf7 is absolutely required for severing of vesicles from the limiting membrane 9, 25, 62 . It remains to be understood how each of the ESCRT-III proteins, which share similar structures and can form similar polymers in vitro either alone or in pairs, have what seem to be different roles in the scission reaction. Some differences can be attributed to the unique binding partners of the proteins, but more fundamental variations seem likely. A simple hypothesis, which has yet to be tested, would be that the scission-competent proteins (that is, Snf7 working in conjunction with Vps20 and Vps24) form stronger interactions with the membrane than do other ESCRT-III subunits.
Finishing up: ESCRT-III disassembly
A defining feature of the ESCRT pathway is the requirement for the AAA+ ATPase Vps4 to disassemble ESCRT-III polymers (FIG. 3c) . This ATP hydrolysis re action is the only energy input into the system and provides the sole thermodynamic driving force for ESCRTmediated membrane budding and scission. The role of Vps4 seems to be conserved in all ESCRT-dependent processes, including viral budding, cytokinesis and autophagy.
Disassembly 22, 57, 70 and recycling 25 of ESCRT-III by Vps4 have been reconstituted in vitro, and early studies showed that without Vps4 activity the entire ESCRT machinery accumulates on membranes and cargo processing through the late endosomal pathway is blocked 71, 72 . The simplest model for Vps4 function is that it acts by disassembling ESCRT-III after membrane scission is complete. Deletion of Vps4 increases the . Helices α1-α4 form the core of the protein, are responsible for membrane binding and polymer assembly and are regulated by autoinhibitory sequences in α5 and the carboxy-terminal microtubule-interacting and transport (MIT)-interacting motif 1 (MIM1; not resolved in the VPS24 structure). All ESCRT-III proteins contain the α1-α4 core and the α5 autoinhibitory sequence. VPS2, DOA4-independent degradation protein 2 (DID2) and VPS24 contain a carboxy-terminal MIM1, whereas VPS20 and SNF7 contain a C-terminal MIM2. Increased sodium tolerance protein 1 (IST1) has both MIM1 and MIM2 at its C terminus. Both types of MIM bind to the MIT domain of VPS4, but they do so at separate sites and do not compete with one another. Structural and biochemical studies suggest that Vps4 functions similarly to other unfolding AAA+ ATPases as a ring-shaped dodecameric cylinder [73] [74] [75] [76] [77] [78] (FIG. 6a) .
Conserved amino acid residues in the central pore of Vps4 are required for function 73 . Current models posit that ESCRT-III subunits are pulled into and potentially through a central pore to release them from a membrane-bound ESCRT-III polymer into the cytosol as monomeric subunits [73] [74] [75] (FIG. 6b) . Initial binding of Vps4 to its ESCRT-III substrates requires the enzyme's N-terminal microtubule-interacting and transport (MIT) domain, which interacts specifically with short α-helical MIT-interacting motifs (MIMs) at or near the C termini of individual ESCRT-III proteins. Structural studies show that there are at least two types of MIM (MIM1 and MIM2), which interact in different ways with the Vps4 MIT domain [79] [80] [81] . MIM1 in the ESCRT-III protein Vps2 has the highest affinity for Vps4, and, correspondingly, Vps2 is essential for ESCRT-III disassembly in vitro 25 and in vivo 62 , even though it is not required for membrane scission.
The high concentration of MIMs present when ESCRT-III proteins assemble into polymers seems to be important not only for engaging individual Vps4 subunits but also for promoting their assembly into a functional AAA+ dodecamer. The assembly of Vps4 into a dodecamer seems to be a crucial regulatory step because the enzyme is an inactive monomer or dimer in the cytosol and seems to assemble only transiently into its oligomeric and active state on substrates 73, 75, 82 . Therefore, Vps4 is in a sense a substrate-activated enzyme. Direct visualization of a Vps4 oligomer during ESCRT-III disassembly has not been feasible to date, leaving some questions about whether Vps4 functions as the asymmetric dodecamer seen when ATP hydrolysis is blocked 74, 77 or in some other form. At least two and potentially as many as four additional proteins bind to Vps4 and have roles in regulating its oligomeric state and activity. The beststudied of these is Vta1 (TABLE 1) , which is a dimer that binds to a unique β-domain in the Vps4 AAA+ module to promote Vps4 oligomerization and contributes MIT domains to a Vps4-Vta1 complex 83 . Additional proteins that regulate Vps4 include Did2, Ist1 and Vps60 (TABLE 1) . Did2 is thought to be a positive regulator 19 and Ist1 a negative regulator 84, 85 of Vps4 function, although the coordination of these proposed roles when everything is present together in vivo remains to be clarified. A recent study in yeast shows that these Vps4 regulatory proteins An important outstanding question is how Vps4 interacts with and disassembles the abundant Snf7 from ESCRT-III polymers, given that the two proteins (through MIM2 in Snf7) have a low-affinity, yet functionally important, interaction 81, 86 . Mechanistically, it will be integral to determine how much of a conformational change Vps4 induces in ESCRT-III proteins to disassemble ESCRT-III polymers. Will the reaction follow the paradigm established for protease-associated AAA+ ATPases, in which molecules are unfolded by using repeated cycles of ATP hydrolysis to pull native proteins into and through the enzyme's central pore 87 ? Or will Vps4 induce a more restricted conformational change that perturbs enough of the subunit to release it and thereby disassemble the ESCRT-III polymer? Will Vps4 function processively on ESCRT-III filaments or, instead, remodel targeted regions to more dynamically control ESCRT-III structure and function? Answers to these and many other questions promise to shed light on this fascinating area of cell biology.
Others roles of the ESCRT machinery
The recent advances described above have led to the development of a working model of scission in MVB biogenesis and have also furthered our understanding of the role of the ESCRT machinery in other processes (FIG. 1) . A seemingly general model is that ESCRT-III assembles at a membrane neck and cleaves it.
Cytokinesis. In cytokinesis, the narrow membrane neck between dividing cells must be severed as the final step in their separation. ESCRT proteins are thought to have a direct role in this process because they have the ability to sever membrane necks and they localize to the site of neck severing at the midbody. This reaction is conserved even in a subset of archaea, the genomes of which encode ESCRT-III and Vps4 orthologues but not ESCRT-0, ESCRT-I and ESCRT-II 88, 89 . Studies have shown that cytokinesis requires ESCRT-III, VPS4 and, to varying extents, ESCRT-I and ALIX, but not ESCRT-0 and probably not ESCRT-II. Specifically, the actomyosin contractile ring and microtubule dynamics create and extend the membrane neck, to which the centrosomal protein of 55 kDa (CEP55) and then ESCRT-I and ALIX are subsequently recruited; ESCRT-I and ALIX then recruit ESCRT-III 12, 13, 49, 90 . However, other models pre-dating the discovery of the role of ESCRTs remain to be fully reconciled with this concept 91 . Cytokinetic membrane neck cleavage by the ESCRTs has at least one unique requirement. The cytokinetic membrane neck surrounds the microtubule-based central spindle, so membrane cleavage is obstructed until the spindle is cleaved. Completion of cytokinesis requires the recruitment of the microtubule-severing enzyme spastin, which is thought to cleave the microtubules of the central spindle. Spastin is recruited by the human ESCRT-III subunit DID2B 92, 93 (TABLE 1) . This illustrates how specialized ancillary functions of ESCRT-III can be coordinated with the principal function of membrane scission. . A molecule of Vps20 initiates ESCRT-III assembly (1) . In yeast cells, at least two copies of Vps20 are required to initiate the scission-competent assembly of ESCRT-III 53, 56 . Multiple Snf7 molecules 57 polymerize downstream of Vps20 (2). One or a few molecules of Vps2 and Vps24 close the spiral, with only Vps24 minimally required for scission (3) . Vps4 breaks up the ESCRT-III polymer at the expense of ATP hydrolysis (4) . c | Integration of budding and scission. After assembling in the bud neck as depicted in FIG. 4 Viral budding. Once membrane-enveloped viruses have completed replication, they exit the infected cell through budding. With a few exceptions, the most notable being influenza virus, most membrane-enveloped viruses depend on the ESCRT machinery for budding 94 . By far the most intensively studied of all the viral budding pathways is that of HIV-1.
For HIV-1 budding, ESCRT proteins are recruited to nascent virions in a process required for their detachment from the plasma membrane, again consistent with a direct role for the ESCRT machinery in membrane severing. Studies have shown that HIV-1 budding, like cytokinesis, requires ESCRT-III, VPS4, ESCRT-I and ALIX, but not ESCRT-0 and ESCRT-II 68 . The lack of ESCRT-0 and ESCRT-II dependence makes sense in that the cargo clustering role of ESCRT-0 is not relevant in this context. The ESCRT-I recruitment function of ESCRT-0 and the bud formation function of ESCRT-II are both supplanted by HIV-1 Gag. The one aspect of the ESCRT-II independence of HIV-1 budding that is puzzling is that it is not clear what replaces the ESCRT-III recruitment and activation function of ESCRT-II in this setting.
In the case of HIV-1 budding, the viral Gag protein can assemble and drive bud formation, but not scission, independently of the ESCRTs 95, 96 .The ESCRTs, which are required for virion release, assemble to sever the membrane neck connecting the viral bud to the plasma membrane 24, 97 . When ALIX recruits SNF7 for membrane scission, it does so directly and can thereby activate ESCRT-III. It is still not clear whether ESCRT-I similarly recruits and activates ESCRT-III or whether the link between these complexes is indirect. In a twist to the simple picture of ESCRT-independent budding and ESCRT-dependent scission, tomographic analysis shows that the viral capsid in the nascent uncleaved bud forms a more closed structure when ESCRT subunits are missing 97 . This suggests that ESCRT-mediated cleavage of viral buds occurs well before closure of the Gag lattice and may compete with complete Gag assembly. The mechanism of membrane scission in HIV-1 budding is probably similar to what occurs during cleavage of ILVs in MVB biogenesis. As above, the main difference is that VPS20 is dispensable, thus this step in the initiation of ESCRT-III assembly seems to be bypassed. It is easy to understand how SNF7 could be activated by ALIX without VPS20, as SNF7 binds directly to the ALIX Bro1 domain [98] [99] [100] [101] . It is less clear how SNF7 is activated downstream of ESCRT-I, and this is perhaps the most important gap in our understanding of this pathway.
Autophagy.
Autophagy is now known to be responsible not only for bulk consumption of cytosol during starvation but also for a range of processes of intense interest in medicine, including degradation of damaged mitochondria, breakdown of lipid droplets, degradation of potentially pathogenic inclusions of aggregated proteins and regulation of cell growth and inflammation. All of these processes involve the formation of a unique doublemembrane phagophore, which eventually forms an autophagosome 102 . An autophagosome is topologically equivalent to an MVB and contains a single, large ILV that fills the entire structure. Thus, the closure of the phagophore is topologically equivalent to ILV scission into an MVB. The entire ESCRT machinery is required for autophagy 103 , and it is tantalizing to speculate that phagophore closure operates by the same mechanism as ILV scission. However, because there is only one short-lived neck per phagophore, it is exceptionally difficult to analyse this event experimentally. There is currently no direct evidence for ESCRT recruitment to this neck. Other possible models for the role of ESCRTs in autophagy were recently discussed 103 . The fact that autophagy, similar to MVB biogenesis, seems to require all of the core ESCRTs, suggests that there is a deeper relationship between the two pathways. It seems possible that the ESCRTs might have multiple roles in autophagy -perhaps a direct one in phagophore closure and an indirect one in maintaining a pool of MVBs to fuse with maturing autophagosomes. 
Conclusions
Our understanding of membrane deformation and scission by the ESCRTs has made stunning advances over the past 2 years. We now know that the ESCRTs have an intrinsic budding and scission activity that is focused on the neck of the nascent bud. These mechanisms differ markedly from the familiar mechanisms in vesicular trafficking that depend on outer coats and in viral budding, in which Gag proteins form inner coats. The biophysical underpinnings of these new mechanisms are beginning to be elucidated by computational and other methods. Many questions, such as how ESCRT-I and ESCRT-II assemble in three dimensions to drive membrane budding, remain open. The coupling of ESCRT-I, ESCRT-II and ESCRT-III (FIG. 5c) depends on the interaction of ESCRT-II with the ESCRT-III protein Vps20, but the nature of the membrane-bound assembly of all the ESCRTs remains to be fully explored. The determinants for ILV size in vivo are also uncertain.
Membrane mechanical properties are undoubtedly a factor in controlling ILV size, but kinetic factors such as the rate of cargo addition and vesicle scission are likely to matter as well. More sophisticated reconstitution studies may help to address the relative roles of kinetic and equilibrium factors in regulating ILV size.
The new mechanistic information also provides the foundation for understanding the role of ESCRTs in detaching viral buds and cleaving cytokinetic membrane necks. Whether the ESCRTs have a similar direct neck closure reaction in autophagy, as opposed to an indirect role of some sort, will be an important question to resolve. The fundamental mechanisms of the ESCRTs have progressed from an almost complete mystery just 3 years ago to a reasonably complete outline today. Elucidating these mechanisms will help to uncover the details of the coupling and regulation of ESCRT-mediated budding in normal physiology and disease.
